Stock Earnings

Question 1

What are Neximmune Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Neximmune Inc has a total asset of $8, Net loss of $0

Question 2

What are the key financial ratios for NEXI?

Accepted Answer

Neximmune Inc's Current ratio is 1.6, has a Net margin is 0, sales per share of $0.

Question 3

How is Neximmune Inc's revenue broken down by segment or geography?

Accepted Answer

Currently Neximmune Inc data is not available.

Question 4

Is Neximmune Inc profitable?

Accepted Answer

no, according to the latest financial statements, Neximmune Inc has a net loss of $0

Question 5

Does Neximmune Inc have any liabilities?

Accepted Answer

yes, Neximmune Inc has liability of 5

Question 6

How many outstanding shares for Neximmune Inc?

Accepted Answer

Neximmune Inc has a total outstanding shares of 1.06

Breakdown	TTM	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019
Revenue	0	--	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	10	--	16	16	10	5
Research & Development	9	--	46	37	17	14
Operating Expenses	20	--	63	53	27	20
Other Non Operating Income (Expenses)	0	--	0	0	0	0
Pretax Income	-20	--	-62	-50	-29	-20
Income Tax Expense	--	--	--	--	--	--
Net Income	-20	--	-62	-51	-33	-23
Net Income Growth	-57.99%	--	22%	55%	43%	64%
Shares Outstanding (Diluted)	1.38	--	0.96	0.81	0.86	0.86
Shares Change (YoY)	33%	--	19%	-6%	0%	0%
EPS (Diluted)	-14.93	--	-65.11	-63.3	-38.54	-26.98
EPS Growth	-68%	--	3%	64%	43%	56%
Free Cash Flow	-17	-31	-52	-48	-27	-20
Free Cash Flow Per Share	-12.31	--	-54.16	-59.25	-31.39	-23.25
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	--	0%	0%	0%	0%
Profit Margin	0%	--	0%	0%	0%	0%
Free Cash Flow Margin	0%	--	0%	0%	0%	0%
EBITDA	-20	--	-63	-53	-27	-20
EBITDA Margin	0%	--	0%	0%	0%	0%
D&A For EBITDA	0	1	0	0	0	0
EBIT	-20	--	-63	-53	-27	-20
EBIT Margin	0%	--	0%	0%	0%	0%
Effective Tax Rate	--	--	--	--	--	--

Neximmune Inc (NEXI) Price